Fundraising Fox

Liquet Medical

Glen Allen, US · Founded 2021 · Delaware corporation · 4 employees on LinkedIn · 1 known investors

Find your way into Liquet Medical

142 people in our graph share verified history with the Liquet Medical team — schools, employers, funds. One of them is your warm intro.

Abe Murrayunlockedknows Derek Hall · together at Worcester Polytechnic Institute (overlapped)
×10knows the team · via Worcester Polytechnic Institute
knows the team · via Atrium Medical

Liquet Medical develops localized drug delivery technology for treating vascular disease. The company focuses on medical devices aimed at improving patient outcomes in vascular care.

Founders & leadership

Liquet Medical was founded in 2021 by John Schindler and Derek Hall.

JSJohn Schindler
John SchindlerinCEO, Co-Founder, Board MemberCo-founder and CEO of Liquet Medical, which develops localized drug delivery technology for treating vascular disease. Schindler has focused on product and market development, business development, and sales training and management.
DHDerek Hall
Derek HallinCOO, Co-Founder, Board MemberDerek Hall is Co-Founder and COO of Liquet Medical, which develops localized drug delivery technology for vascular disease. He has experience in medical device design and development, clinical sales leadership, and holds a Master's degree in Biomedical Engineering.
PH
Paul H. SartoriNamed on SEC filing
GC
Gary C. CupitNamed on SEC filing
KS
Koren SchindlerNamed on SEC filing

Board

GN
Gabriele NiederauerBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$3.3M disclosed across 6 rounds · 2021–2026

$75KraisedMar 2026 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul SartoriDirector
  • Derek HallExecutive Officer, Director
  • Mary ByronDirector
  • Gabriele NiederauerDirector
  • John SchindlerExecutive Officer, Director
Offering amount
$1.5M
Amount sold
$75K
First sale
Mar 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.1MraisedMay 2025 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Gabriele NiederauerDirector
  • Derek R. HallExecutive Officer, Director, Promoter
  • John J. SchindlerExecutive Officer, Director, Promoter
  • Paul H. SartoriDirector, Promoter
Offering amount
$1.5M
Amount sold
$1.1M
Minimum investment
$25K
First sale
Dec 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$615KraisedMay 2025 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul H. SartoriDirector, Promoter
  • Gabriele NiederauerDirector
  • John J. SchindlerExecutive Officer, Director, Promoter
  • Derek R. HallExecutive Officer, Director, Promoter
Offering amount
$800K
Amount sold
$615K
Minimum investment
$10K
First sale
Dec 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$405KraisedMay 2023 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul H. SartoriExecutive Officer, Director, Promoter
  • Derek R. HallExecutive Officer, Director, Promoter
  • John J. SchindlerExecutive Officer, Director, Promoter
  • Gary C. CupitDirector, Promoter
  • Koren SchindlerExecutive Officer, Promoter
Offering amount
$1M
Amount sold
$405K
First sale
Apr 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$605KraisedJun 2022 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Derek HallExecutive Officer, Director, Promoter
  • Koren SchindlerExecutive Officer, Promoter
  • Paul SatoriExecutive Officer, Director, Promoter
  • Gary CupitDirector, Promoter
  • John SchindlerExecutive Officer, Director, Promoter
Offering amount
$1.4M
Amount sold
$605K
Minimum investment
$25K
First sale
May 2022
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$550KraisedOct 2021 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John SchindlerExecutive Officer, Director, Promoter
  • Koren SchindlerExecutive Officer, Promoter
  • Gary CupitDirector, Promoter
  • Derek HallExecutive Officer, Director, Promoter
  • Paul SartoriDirector, Promoter
Offering amount
$2M
Amount sold
$550K
First sale
Oct 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Companies competing with Liquet Medical for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Liquet Medical do?
Liquet Medical develops localized drug delivery technology for treating vascular disease. The company focuses on medical devices aimed at improving patient outcomes in vascular care.
Who founded Liquet Medical?
Liquet Medical was founded by John Schindler, Derek Hall in 2021.
Who are Liquet Medical's investors?
Liquet Medical's investors include Lighthouse Network Ventures Llc.
How much funding has Liquet Medical raised?
Liquet Medical has disclosed $3.3M raised across 6 rounds.
Where is Liquet Medical headquartered?
Liquet Medical is headquartered in Glen Allen, US.